Skip to main content
Premium Trial:

Request an Annual Quote

University of Utah Licenses Omicia's Opal for Genomic Interpretation

Premium

Omicia and the University of Utah said this week that they have signed a two-year licensing agreement that allows researchers involved in the Utah Genome Project use Opal, Omicia's platform for analyzing genomics in research and clinical applications, to analyze disease causing variants.

The Utah Genome Project is a large-scale, genome sequencing and analysis initiative that aims to discover new disease-causing genes and develop more personalized testing and treatment procedures. Under the terms of the agreement, researchers and clinicians involved in the project will be able to use Opal on a cost-per-genome basis to identify variants that are associated with autoimmune and metabolic disorders and other ailments.

The financial details of the agreement were not disclosed.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.